Background Supply of sulfhydryl groups with the administration of N-acetylcysteine (NAC) has been reported to reverse tolerance to nitroglycerin but not to isosorbide dinitrate (ISDN) 
Potentiation of Isosorbide Dinitrate Effects
With (-11±21% versus -38±27%, -17±20% versus -34±27%, and -7±20% versus -25±26% at 2, 3, and 4 hours, respectively; all P<.05), mean pulmonary artery wedge pressure (-18±16% versus -33±14%, -15±25% versus -33±19%, -14±22% versus -25±22%, and -16±16% versus -26±16% at 2, 3, 4, and 5 hours, respectively; all P<.05), mean pulmonary artery pressure (-8±11% versus -20±15% at 3 hours, P<.05), and cardiac output (an increase of 2±16% versus 25±20% at 4 hours, P<.05). Although there were no significant changes in serum catecholamine levels and plasma renin concentration with both regimens, ISDN+NAC resulted in a greater fall in plasma levels of atrial natriuretic peptide (296±251 pg/mL after ISDN versus 202±118 pg/mL after ISDN+NAC, P<.05).
Conclusions The results of this study provide strong evidence for the existence of an interaction between thiols and ISDN and further support the role of sulfhydryl groups in the activation and therapeutic action of organic nitrates. The discrepancy between the results of this study demonstrating NAC-induced potentiation of ISDN effects and a previous study showing failure to 
Hemodynamic Measurements and Computations
Hemodynamic measurements were obtained with the use of a balloon-tipped, triple-lumen, right heart flotation catheter (Swan-Ganz). Right atrial, pulmonary arterial, and pulmonary artery wedge pressures were recorded on an Electronics for Medicine AR-6 recorder, and mean pressures were obtained with the use of electronic integration. Heart rate was determined from the ECG recordings, and arterial blood pressure was measured by the standard cuff method. Cardiac outputs were obtained by the thermodilution method as previously described. 16 Mean systemic arterial pressure, cardiac index, systemic vascular resistance, and pulmonary vascular resistance were calculated by standard formulas.
Study Protocol
All patients were enrolled in the study after being clinically stabilized and signing a consent form. Evaluation began at least 24 hours after insertion of a right heart balloon flotation catheter to guard against previously reported spontaneous hemodynamic fluctuations after the procedure.17 Vasodilator agents including organic nitrates were discontinued at least 24 hours before initiation of the study. Usual doses of digitalis and oral furosemide were continued throughout the study period. To ensure hemodynamic stability, baseline hemodynamic measurements were obtained every 30 minutes to obtain two consecutive measurements with <10% variability in mean pulmonary artery wedge pressure. Hemodynamic values obtained at the last measurements were used as baseline values. After the determination of baseline hemodynamic and hormonal values, patients were randomized to receive 40 mg of oral ISDN (11 patients) or 120 mg (in 3 patients not responding to the smaller dose) either alone or after intravenous infusion of NAC (Bristol-Myers Squibb Corporation). Hemodynamic measurements were repeated hourly for 6 hours, and determination of plasma hormonal values was repeated 2 hours after ISDN administration. A washout period of at least 24 hours was allowed after the administration of the first dose of ISDN to achieve a return of hemodynamic and hormonal values to baseline. All patients were then crossed over to receive the second regimen. Seven patients received oral ISDN alone as their first regimen; the other 7 patients received ISDN after an infusion of NAC.
ISDN+NAC Administration
NAC was administered intravenously via a peripheral vein in an infusion of 100 mg/kg body wt diluted in 200 mL of 5% dextrose solution given over 30 minutes followed by administration of 40 to 120 mg of oral ISDN. All patients were monitored closely throughout the study period for any adverse effects to administration of intravenous NAC. Patients with a history of allergy to sulfur-containing substances or chronic obstructive pulmonary disease were excluded from the study.
Plasma Neurohormonal Measurements
Venous blood samples for plasma catecholamines, renin activity, and atrial natriuretic peptide (ANP) were obtained at baseline each day and 2 hours after the administration of ISDN alone and in combination with NAC. The determination of both epinephrine and norepinephrine was performed with an isotope radioenzymatic technique.18 Plasma renin activity was determined by radioimmunoassay of angiotensin I after addition of excess sheep angiotensinogen.'9 ANP was measured by radioimmunoassay technique20 (RIA kit, TRK.500, Amersham Corporation). Determinations of plasma neurohormonal values were performed by outside laboratories in a blinded fashion.
Statistical Methods
The temporal changes in hemodynamic and hormonal values were analyzed within each treatment group by ANOVA for repeated measurements and the Newman-Keuls test. All data comparisons between the two groups were made by two-tailed paired t test. A probability value of <.05 was considered statistically significant. All group values were presented as mean±SD. Analysis was performed with the CLINFO system and SAS statistical package on an IBM 370 system at the University of Southern California.
Results

Comparison of Baseline Hemodynamic and Hormonal Values in Study Days 1 and 2
Baseline data as determined before drug administration on both study days showed no statistically significant difference between any of the hemodynamic or hormonal values (Tables 1 and 2 Although the present study was performed in a randomized, crossover fashion, it is limited by its unblinded determinations of hemodynamic parameters. This limitation may be minimized by supportive changes in ANP, which was determined blindly. The failure to have a separate determination of the hemodynamic effect of NAC may be another potential limitation of the present study. However, lack of intrinsic vasodilator effect of NAC has been well demonstrated in previous studies in patients with ischemic heart disease12,36 and in patients with chronic CHF. 13 Although the immediate clinical applicability of the results of our study are limited, a better understanding of thiol-nitrates interaction may prove in the future to be therapeutically useful for potentiation of nitrates effect and prevention of nitrate tolerance. 37 
Summary
This study demonstrates an augmentation of the hemodynamic and hormonal effects of oral ISDN after exogenous sulfhydryl group supplementation through the administration of intravenous NAC. Our findings therefore dispute previous suggestions for lack of interaction between NAC and ISDN due to slow NACcatalyzed production of S-nitrosothiol from ISDN. The potentiation of the initial effect in contrast to the previously reported failure to reverse ISDN tolerance with NAC may suggest that NAC-ISDN interaction requires a normal level of intracellular sulfhydryl group and may not occur in intracellularly sulfhydryl-depleted state.
